Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 489Erstellt: 23. Oktober 2026

2-Chloropyridine → Ethyl 2-(pyridin-2-ylamino)-1,3-oxazole-5-carboxylate

https://huagongshe.com/de/reaction/489

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Edukt2-ChloropyridineHCID 7977—
EduktEthyl 2-amino-1,3-oxazole-5-carboxylateHCID 5260193—
ReagenzCesium carbonateHCID 10796—
Katalysator1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
KatalysatorBis(dibenzylideneacetone)palladiumHCID 9811564—
Lösungsmittel1,4-DioxaneHCID 31275—
ProduktEthyl 2-(pyridin-2-ylamino)-1,3-oxazole-5-carboxylateHCID 10158450137,77%

Reaktionsbedingungen

Temperatur160 °C

Reaktionsschritte

Objective: To test the substrate scope in 5-ester substituted 2-aminooxazole coupling. TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (22.87 mg, 0.02 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (43.4 mg, 0.075 mmol), cesium carbonate (651 mg, 2.00 mmol), ethyl 2-aminooxazole-5-carboxylate (156 mg, 1.00 mmol) and 2-chloropyridine (113 mg, 1.00 mmol) were placed in an oven dried microwave vial. The vial was then capped and placed under an inert atmosphere. Dioxane (4 mL) was added and the mixture was heated to 160 °C for 1 h under microwave irradiation. LCMS of the crude reaction mixture indicated the presence of the desired product. DCM (10 mL) was added to the crude reaction mixture together with C-18 silica (2 g), and the solvent was removed under reduced pressure. The solid residue was then placed in a dry-load tube prior to chromatography. The crude product was purified by reverse-phase flash chromatography on C-18 silica, elution gradient 10 to 60% MeCN in water (1% ammonium hydroxide). Pure fractions were evaporated to dryness to afford ethyl 2-(pyridin-2-ylamino)oxazole-5-carboxylate (88 mg, 37.8 %) as a beige solid. Conclusion: The desired product was isolated in moderate yield, but in only 84% purity based on LCMS.

Herkunft & Nachweise

Quelldatensatz750 AstraZeneca ELN dataset
ORD IDord-43f679e964f04e22b49e850c529e3849
Quellennotiz750 AstraZeneca ELN dataset